KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBT Margin (2016 - 2026)

Idexx Laboratories has reported EBT Margin over the past 17 years, most recently at 28.15% for Q4 2025.

  • For Q4 2025, EBT Margin rose 128.0% year-over-year to 28.15%; the TTM value through Dec 2025 reached 30.77%, up 229.0%, while the annual FY2025 figure was 30.77%, 229.0% up from the prior year.
  • EBT Margin for Q4 2025 was 28.15% at Idexx Laboratories, down from 31.19% in the prior quarter.
  • Over five years, EBT Margin peaked at 32.66% in Q2 2025 and troughed at 19.88% in Q2 2022.
  • A 5-year average of 28.38% and a median of 29.06% in 2022 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: crashed -1059bps in 2022 and later soared 1042bps in 2023.
  • Year by year, EBT Margin stood at 23.95% in 2021, then rose by 7bps to 25.73% in 2022, then rose by 3bps to 26.58% in 2023, then rose by 1bps to 26.87% in 2024, then rose by 5bps to 28.15% in 2025.
  • Business Quant data shows EBT Margin for IDXX at 28.15% in Q4 2025, 31.19% in Q3 2025, and 32.66% in Q2 2025.